Redpoint Investment Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Redpoint Investment Management's ELV Position: Q3 2022 in Review
Redpoint Investment Management reduced its Elevance Health (ELV) stake by 14% in Q3 2022, selling an estimated $380K and leaving 5,081 shares worth $2.31M. The position accounts for 0.34% of the portfolio, ranked #66.
Redpoint Investment Management first reported a position in ELV in Q4 2017 and has held it in 20 quarters since. The position peaked at $5.01M in Q1 2019. 1,445 funds tracked by Wall St. Rank hold ELV as of Q3 2022.
- Redpoint Investment Management held 5,081 shares of Elevance Health worth $2.31M as of Q3 2022.
- Redpoint Investment Management sold 794 Elevance Health shares in Q3 2022, an estimated $380K.
- Elevance Health made up 0.34% of Redpoint Investment Management's portfolio in Q3 2022, its #66 holding.
- Redpoint Investment Management first reported a position in Elevance Health in Q4 2017 and has held it in 20 quarters since.
- Redpoint Investment Management's Elevance Health position peaked at $5.01M in Q1 2019.
- 1,445 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.
Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.